- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/564 - ImmunoassayBiospecific binding assayMaterials therefor for pre-existing immune complex or autoimmune disease
Patent holdings for IPC class G01N 33/564
Total number of patents in this class: 2262
10-year publication summary
148
|
193
|
163
|
158
|
152
|
136
|
128
|
123
|
115
|
69
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Mayo Foundation for Medical Education and Research | 3222 |
34 |
The Johns Hopkins University | 5675 |
32 |
EUROIMMUN Medizinische Labordiagnostika AG | 224 |
29 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3361 |
29 |
The Regents of the University of California | 19961 |
27 |
The Board of Trustees of the Leland Stanford Junior University | 6428 |
27 |
Prometheus Laboratories Inc. | 94 |
24 |
Oklahoma Medical Research Foundation | 157 |
23 |
iNova Diagnostics, Inc. | 67 |
21 |
CellTrend GmbH | 29 |
19 |
F. Hoffmann-La Roche AG | 7947 |
18 |
Laboratory Corporation of America Holdings | 816 |
17 |
The Board of Regents of the University of Texas System | 2210 |
17 |
Genentech, Inc. | 3976 |
16 |
Institut National de La Sante et de La Recherche Medicale (inserm) | 2849 |
16 |
Centre National de La Recherche Scientifique | 10464 |
15 |
Institut Pasteur | 784 |
13 |
Yeda Research and Development Co. Ltd. | 1339 |
13 |
The General Hospital Corporation | 4740 |
12 |
Allegheny-Singer Research Institute | 90 |
12 |
Other owners | 1848 |